The DYSF gene gives muscle cells instructions to make dysferlin, a protein that helps patch tiny tears in the cell membrane after everyday movement. Your cells depend on this gene when they need to repair muscle damage from walking, lifting, or exercise. If you carry harmful variants in the DYSF gene, muscles may not heal normally, which can lead to gradual weakness and certain forms of muscular dystrophy, including dysferlinopathy. Symptoms often begin in adolescence or adulthood and may affect the legs, hips, shoulders, or calves.
What is a gene?
Genes are stretches of DNA that give your cells instructions for making molecules or directing processes in the body. Some genes carry the information needed to produce proteins, the parts of cells that do the work. Other genes are used mainly to control when certain processes happen, where they happen, and how strongly they run. Taken together, genes affect how the body grows and works, and they can also shape how you respond to food, stress, or medications. To go further into this topic, you can read more in the LearnHub.
Overview
DYSFGene function
What if the gene works
The DYSF gene helps muscle cells repair small tears in their outer covering after everyday use. This supports muscle strength and healthy muscle maintenance.
Risk
What if the gene does not work
When the DYSF gene does not work properly, it can cause dysferlinopathy, with muscle weakness in the hips, shoulders, or lower legs. Variants range from milder to more severe, which can affect when symptoms start and which muscles are involved.
Treatment
What does that mean for your treatment
No treatment, drug choice, or management approach specific to pathogenic variants in the DYSF gene is currently established. Research is exploring dysferlin replacement and gene or cell therapies, but these are not yet part of routine care.
Conditions associated with DYSF
Gene function
What if the gene works
If you carry the DYSF gene, it helps your muscle cells handle everyday wear from walking, climbing stairs, and exercise. Its protein is especially important at the cell surface, where it helps repair tiny areas of damage. This routine upkeep supports normal muscle function over time.
The DYSF gene helps repair tiny tears in the muscle cell membrane after normal movement and strain. Its protein gathers repair material at the injured spot so the cell surface can seal and keep working smoothly.
Inside muscle cells, the protein made from the DYSF gene helps small membrane bubbles move to and join the cell surface when repair is needed. This controlled joining process supports muscle cell membrane repair during everyday activity.
What is a variant?
A genetic variant is a minor change in the DNA sequence within a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not cause any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can affect how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the DYSF gene often change the dysferlin protein so it is shortened, unstable, or made in much smaller amounts, leaving muscle cells less able to patch tiny membrane injuries. In dysferlinopathy, milder variants in the DYSF gene may leave some protein activity, while more severe variants can lead to little or no working protein. This difference in how variants in the DYSF gene affect muscle cell repair can influence when symptoms begin and how much muscle weakness develops.
How variants are linked to conditions
Pathogenic variants in the DYSF gene cause dysferlinopathy, a group of inherited muscle conditions that includes limb-girdle muscular dystrophy type R2 and Miyoshi muscular dystrophy type 1. DYSF gene variants linked to muscular dystrophy are most often associated with progressive weakness in the hips, shoulders, or lower legs. Some people also have high creatine kinase, a muscle enzyme, on blood tests even before weakness becomes clear.
A variant is not necessarily a diagnosis
Variants in genes are a routine feature of human biology and are widely seen across the population. Most do not directly affect health and simply reflect normal human variation. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences contribute. There are cases, though, where one well understood variant in a particular gene is enough to establish a diagnosis.
Are there things that can increase or change my risk?
For DYSF, the main factor is genetics: people usually develop a DYSF-related muscle condition only if they inherit changed copies from both parents. Family history and having a partner who also carries a DYSF change can raise the chance of having an affected child. There is not enough evidence to say lifestyle changes lower this inherited risk.
Inheritance of DYSF variants
DYSF-related conditions are inherited in an autosomal recessive pattern. In practical terms, how DYSF gene variants are inherited usually means a person develops disease only after receiving one nonworking copy of the DYSF gene from each parent. When both parents carry one DYSF variant, each pregnancy has a 25% chance of an affected child, a 50% chance of a child who is a carrier, and a 25% chance of a child with two working copies. Sons and daughters are affected at similar rates.
What does my DYSF result mean for my family?
For families with a DYSF-related muscle condition, close relatives may also carry a changed DYSF gene, even if they do not have symptoms. Brothers and sisters may be affected or may be carriers, and other relatives may also want to learn whether the change runs in the family. This is usually passed down in a recessive pattern, so family planning questions often center on whether both parents carry a DYSF change.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the DYSF gene, genetic testing for the DYSF gene usually uses a blood or saliva sample. A lab reads the gene’s DNA code and looks for changes, including small spelling differences and, in some cases, missing or extra sections.
When should I consider getting a genetic test?
Consider testing the DYSF gene if there is unexplained muscle weakness, trouble running or climbing stairs, very high muscle enzyme levels on blood tests, or a family history of an inherited muscle condition linked to DYSF. Testing can help confirm whether this gene is the cause and may clarify risks for relatives.
A genetic result is only one part of your health story
A genetic result can be informative, but how much it explains depends on the condition and the kind of variant involved. Factors like lifestyle, environment, age, and medical history also influence how the body functions over time. For some conditions, particularly those shaped by many genes, genetic information provides context rather than certainty and makes the most sense when considered with other parts of care. In other situations, a genetic result can offer a clear answer. In areas like medication response, genetic results can also help put personal experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Small differences in genes can change how a drug is absorbed, broken down, moved through the body, or how strongly it acts at its target. This helps explain why the same treatment may work well for one person, have less effect in another, or cause more side effects in someone who is more sensitive.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes shape the way a person responds to medicines. It studies the relationship between genes and drugs to help explain why the same treatment can work differently from one person to another. For many medicines, genes influence both how strongly a drug works and how the body handles it. This information can support treatment decisions that are more informed and more individualized. To explore this subject in greater detail, you can learn more in the LearnHub.
Drugs influenced by the DYSF gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how medicines will work, so any concerns about medications, side effects, or changes in your health are best discussed with your doctor.
History
Throughout history, people have described muscle weakness patterns that often began in the calves or hips and appeared in more than one family member. Initially understood only through visible traits, later recognized as tied to a specific gene, these conditions were described under names such as Miyoshi myopathy and limb girdle muscular dystrophy type 2B. In the late 1990s, researchers identified the DYSF gene as the shared cause in many of these families, bringing together conditions that had seemed separate. This discovery helped doctors recognize dysferlin related muscle conditions as part of one broader group. Over time, descriptions became more precise, and genetic testing made it easier to confirm the diagnosis. Each stage in history has added to the picture we have today.